PT1449922E - Fragmentos de ácidos nucleicos e fragmentos polipeptídicos obtidos a partir de m. tuberculosis - Google Patents

Fragmentos de ácidos nucleicos e fragmentos polipeptídicos obtidos a partir de m. tuberculosis Download PDF

Info

Publication number
PT1449922E
PT1449922E PT04076605T PT04076605T PT1449922E PT 1449922 E PT1449922 E PT 1449922E PT 04076605 T PT04076605 T PT 04076605T PT 04076605 T PT04076605 T PT 04076605T PT 1449922 E PT1449922 E PT 1449922E
Authority
PT
Portugal
Prior art keywords
polypeptide
fragment
tuberculosis
sequence
vaccine
Prior art date
Application number
PT04076605T
Other languages
English (en)
Portuguese (pt)
Inventor
Peter Birk Rasmussen
Peter Andersen
Walter Florio
Thomas Oettinger
Ida Rosenkrands
Rikke Louise Vinther Skjoet
Karin Weldingh
Original Assignee
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Seruminstitut filed Critical Statens Seruminstitut
Publication of PT1449922E publication Critical patent/PT1449922E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
PT04076605T 1997-04-02 1998-04-01 Fragmentos de ácidos nucleicos e fragmentos polipeptídicos obtidos a partir de m. tuberculosis PT1449922E (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK37697 1997-04-02
US4462497P 1997-04-18 1997-04-18
DK127797 1997-11-10
US7048898P 1998-01-05 1998-01-05

Publications (1)

Publication Number Publication Date
PT1449922E true PT1449922E (pt) 2007-11-09

Family

ID=47018662

Family Applications (1)

Application Number Title Priority Date Filing Date
PT04076605T PT1449922E (pt) 1997-04-02 1998-04-01 Fragmentos de ácidos nucleicos e fragmentos polipeptídicos obtidos a partir de m. tuberculosis

Country Status (10)

Country Link
EP (2) EP1449922B1 (cg-RX-API-DMAC7.html)
JP (4) JP4172598B2 (cg-RX-API-DMAC7.html)
AT (1) ATE370236T1 (cg-RX-API-DMAC7.html)
AU (1) AU740545B2 (cg-RX-API-DMAC7.html)
CA (1) CA2285625C (cg-RX-API-DMAC7.html)
DE (1) DE69838268T2 (cg-RX-API-DMAC7.html)
DK (1) DK1449922T3 (cg-RX-API-DMAC7.html)
ES (1) ES2291810T3 (cg-RX-API-DMAC7.html)
PT (1) PT1449922E (cg-RX-API-DMAC7.html)
WO (1) WO1998044119A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
WO1999024577A1 (en) * 1997-11-10 1999-05-20 Statens Serum Institut NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)
AU749672B2 (en) * 1998-03-06 2002-07-04 Statens Serum Institut Production of mycobacterial polypeptides by lactic acid bacteria
AU2594500A (en) * 1998-12-24 2000-07-31 Corixa Corporation Methods for using mycobacterium tuberculosis molecules as immunological adjuvants
WO2000066157A1 (en) 1999-05-04 2000-11-09 The Public Health Research Institute Of The City Of New York, Inc. Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines
US6537552B1 (en) 1999-10-19 2003-03-25 Iowa State University Research Foundation Vaccine adjuvant
AU2001250294A1 (en) * 2000-04-19 2001-10-30 Statens Serum Institut Tuberculosis antigens and methods of use thereof
WO2002004018A2 (en) * 2000-07-10 2002-01-17 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity
WO2004099771A1 (en) * 2003-05-08 2004-11-18 Statens Serum Institut A new specific epitope based immunological diagnosis of tuberculosis
BRPI0518933A2 (pt) 2004-11-16 2008-12-16 Crucell Holland B V E Aeras Gl adenovÍrus recombinante defeituoso de replicaÇço, vetor de polinucleotÍdeo recombinante, vacina multivalente da tuberculose, e, uso do antÍgeno tb10.4 de mycobacterium
WO2007106536A2 (en) * 2006-03-14 2007-09-20 Oregon Health & Science University Methods for producing an immune response to tuberculosis
GB0618127D0 (en) * 2006-09-14 2006-10-25 Isis Innovation Biomarker
EP2087128A4 (en) 2006-11-01 2009-11-04 Immport Therapeutics Inc COMPOSITIONS AND METHODS FOR IMMUNOMINANT ANTIGENES
US20120201846A1 (en) * 2009-07-29 2012-08-09 Bernd Helmut Adam Rehm Polymer particles and uses thereof
WO2011159814A2 (en) * 2010-06-15 2011-12-22 The Regents Of The University Of California Novel live recombinant booster vaccine against tuberculosis
WO2013158061A1 (en) * 2012-04-16 2013-10-24 Aeras Global Tb Vaccine Foundation Recombinant mycobacterium encoding a heparin-binding hemagglutinin (hbha) fusion protein and uses thereof
CN104897838B (zh) * 2015-06-10 2016-08-17 重庆医科大学 一种强极性有机酸碱混合物的同时提取分离分析方法
EP3966321A4 (en) * 2019-05-07 2023-09-06 Nanyang Technological University Asx-specific protein ligases and uses thereof
CN113373162A (zh) * 2020-03-09 2021-09-10 北京蛋白质组研究中心 结核分枝杆菌H37Rv新基因Rv0229A及其编码蛋白和应用
EP4138894A4 (en) * 2020-04-20 2024-06-26 The University of Saskatchewan COMPOSITIONS AND METHODS FOR THE PREVENTION, CONTROL AND DIAGNOSIS OF MYCOBACTERIAL INFECTIONS
CN116082514B (zh) * 2021-11-05 2024-02-13 安博智联(北京)生物科技有限公司 结核分枝杆菌特异性的重组融合蛋白em及其应用
WO2025250534A1 (en) * 2024-05-28 2025-12-04 The Board Of Trustees Of The Leland Stanford Junior University T cell targets for tuberculosis vaccines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
NZ309945A (en) * 1995-05-23 2001-04-27 Univ California Abundant extracellular products and their use as vaccines
EP1203817B9 (en) * 1995-09-01 2006-08-16 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
MX9801687A (es) * 1995-09-01 1998-11-29 Corixa Corp Compuestos y metodos para el diagnostico de tuberculosis.

Also Published As

Publication number Publication date
DK1449922T3 (da) 2007-12-03
ATE370236T1 (de) 2007-09-15
CA2285625C (en) 2015-06-30
JP2008142079A (ja) 2008-06-26
JP2001515359A (ja) 2001-09-18
WO1998044119A1 (en) 1998-10-08
JP4172598B2 (ja) 2008-10-29
EP1449922A2 (en) 2004-08-25
EP1449922B1 (en) 2007-08-15
AU6820498A (en) 1998-10-22
DE69838268T2 (de) 2008-05-08
CA2285625A1 (en) 1998-10-08
JP2010154856A (ja) 2010-07-15
JP4544434B2 (ja) 2010-09-15
DE69838268D1 (de) 2007-09-27
EP1449922A3 (en) 2004-11-17
JP2008301817A (ja) 2008-12-18
AU740545B2 (en) 2001-11-08
JP4406024B2 (ja) 2010-01-27
EP0972045A1 (en) 2000-01-19
ES2291810T3 (es) 2008-03-01

Similar Documents

Publication Publication Date Title
JP4544434B2 (ja) 結核菌由来の核酸フラグメント及びポリペプチドフラグメント
US6991797B2 (en) M. tuberculosis antigens
US8076469B2 (en) TB diagnostic based on antigens from M. tuberculosis
JP4764445B2 (ja) 結核の免疫治療および診断のための化合物およびそれらの使用方法
AU750173B2 (en) Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
ES2229220T3 (es) Vacuna contra la tuberculosis.
US5955077A (en) Tuberculosis vaccine
US7037510B2 (en) Hybrids of M. tuberculosis antigens
US6641814B1 (en) Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis
US20040013685A1 (en) Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
CN101248084B (zh) 包含潜伏感染阶段期间所表达的抗原的结核疫苗
EP1484405A1 (en) Nucleic acid fragments and polypeptide fragments derived from M. Tuberculosis
AU2011200353A1 (en) Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis